Additionally, administration of DYB‐03 did not have a significant inhibitory effect on tumor growth in A549 double knockdown cells, indicating that DYB‐03 exerts antitumor activity by targeting HIF‐1α and EZH2 (Figure 6F,G and Figure S6C, Supporting Information). This evidence concerns the gene EZH2 and neoplasm.